$PFE Q3 '26 Earnings Results & Recap Pfizer raised full-year 2026 Revenue guidance to $62B from $60.5B, and raised and narrowed Adjusted diluted EPS guidance to $2.95 to $3.05 from $2.80 to $3.00.
$PFE Q3 '26 Earnings Results & Recap Pfizer raised full-year 2026 Revenue guidance to $62B from $60.5B, and raised and narrowed Adjusted diluted EPS guidance to $2.95 to $3.05 from $2.80 to $3.00.